600114.SS(600114.SS)

600114.SS

Overview Intelligence Chart Fundamentals Key Metrics Earnings Growth Analysts Financials Insiders Institutional

No data available

Next earnings: Jul 30, 2026

Signal

Bullish Setup3↑

Price

1↑

Move↑+4.16%Strong session

Volume

1↑

Volume↑1.7× avgHeavy volume

Technical

1↑

Trend↑Full UptrendAbove 50D & 200D

PRICE

Prev Close

32.72

Open

33.21

Day Range33.18 – 34.73

33.18

34.73

52W Range18.19 – 37.22

18.19

37.22

83% of range

VOLUME & SIZE

Avg Volume

14.1M

Float

631.4M

FUNDAMENTALS

P/E Ratio

38.7x

EPS (TTM)

$0.88

Div Yield

No dividend

Quick Read

Trend

UPTREND

Price above SMA50 & SMA200

Momentum

BULLISH

price above key MAs · revenue +11% YoY

Valuation

EXPENSIVE

P/E 39x vs ~20x sector

Health

MODERATE

CR 1.4 · FCF $1.48/sh

Trend

Momentum

Valuation

Health

Strong Buy

Composite signal across trend, momentum, valuation & healthSignals from latest available data

Key MetricsTTM

Market Cap$21.52B

Revenue TTM$6.10B

Net Income TTM$549.94M

Free Cash Flow$935.42M

Gross Margin25.4%

Net Margin9.0%

Operating Margin12.7%

Return on Equity16.8%

Return on Assets6.8%

Debt / Equity0.71

Current Ratio1.44

EPS TTM$0.87

Alpha SignalsView Intelligence →

Intelligence analysis not yet available for this stock. Full AI-powered analysis may be available on the intelligence page.

Health Radar

3 strong2 watch1 concern

55/100

Liquidity

1.44Watch

Leverage

0.71Strong

Coverage

11.0xStrong

ROE

16.8%Strong

ROIC

10.7%Watch

Cash

$355MConcern

Analyst Coverage

No analyst coverage available for this stock.

Stock Health

Composite Score

4 of 5 signals bullish

9/10

Trend

●

Trend StateUptrend (price above both MAs)

✓

●

Above SMA 50$31.05 (+9.8%)

✓

●

Above SMA 200$30.22 (+12.8%)

✓

Technicals

●

MA AlignmentGolden Cross (50D vs 200D +2.7%)

✓

Fundamentals

●

LiquidityCurrent Ratio 1.44

Upcoming Events

EEarnings ReportMay 4, 2026

Tomorrow

DEx-Dividend DateJul 31, 2026

In 89 days

Research

Fundamentals→Financials→Analysts→Earnings→Growth→Key Metrics→Technical Analysis→Intelligence→

FinancialsFull statements →

Technicals

Market Position

Price Levels

52W High

$37.22+9.2%

Current

$34.08

SMA 50

$31.05-8.9%

SMA 200

$30.22-11.3%

52W Low

$18.19-46.6%

52-Week RangeNear 52-week high

$18.1983th %ile$37.22

Earnings & Analysts

ANALYST ESTIMATES

Consensus of 5 analysts

Full estimates →

Analyst revisions:EPS↑ Revised UpRevenue↑ Revised Up

Analyst consensus estimates · Actuals replace estimates as reported

Year	Revenue Est.	Rev Gth	EPS Est.	EPS Gth	Range	Analysts
FY2023	$4.5B $4.5B–$4.5B	—	$0.56	—	—	Low2
FY2024	$5.0B $4.9B–$5.1B	▲ +11.6%	$0.65	▲ +16.5%	—	High5
FY2025	$6.1B $6.1B–$6.1B	▲ +22.7%	$0.94	▲ +43.9%	±16%	Low2

Range confidence:Tight (high)ModerateWide (low)

Financials

Dividends0.88% yield

+26.1% avg annual growth

Annual Yield0.88%

Annual Div.$0.3000

Est. Annual / Share$0.30

FrequencyAnnual

Q3'18

Q2'19

Q2'20

Q2'21

Q2'22

Q2'23

Q2'24

Q2'25

Dividend per payment — last 8 periods

News & Activity

600114.SS News

1000 articles · 4h ago

Jobs Report, Palantir, Pinterest, AMD, PayPal, Disney, and More to Watch This Week

ON Semiconductor, Pfizer, Uber, McDonald's, and many more will report earnings this week. Economic r…

barrons.com

etftrends.com

Stock Market Today, May 1: Riot Platforms Jumps After AI Data Center Revenue Beats Estimates

fool.com

Feral X Systems Inc. Announces Name Change, Closing of Private Placement and Execution of Letter of Intent

newsfilecorp.com

About

No company information available

Explore More

S&P 500 Screener

Filter and sort all 500 stocks

Market Movers

Today's biggest gainers and losers

Market Heatmap

Visual sector performance

ANALYST ESTIMATES

600114.SS News

Jobs Report, Palantir, Pinterest, AMD, PayPal, Disney, and More to Watch This Week

Should You Dump Bitcoin for Stocks After the S&P 500 Hit a New Record on Apple's $100 Billion Buyback?

Nostalgia Powers Big Debut for ‘The Devil Wears Prada 2'

Greg Abel earns solid scorecard from Berkshire shareholders after first annual meeting

Belgian pharma group UCB to buy Candid Therapeutics for up to $2.2 billion

Why FormFactor Stock Plummeted This Week

Why Poet Technologies Stock Crashed This Week

This Often Underappreciated Growth Stock Is Holding Its Own Against Giants Amazon and Alphabet. Time to Buy?

Buy These 3 Dividend Stocks Today and Thank Yourself in 20 Years

This Overlooked Precious Metals ETF Offers a 7% Yield

Bronstein, Gewirtz & Grossman LLC Urges Grocery Outlet Holding Corp. Investors to Act: Class Action Filed Alleging Investor Harm

Bronstein, Gewirtz & Grossman LLC Urges zSpace, Inc. Investors to Act: Class Action Filed Alleging Investor Harm

Bronstein, Gewirtz & Grossman LLC Urges monday.com Ltd. Investors to Act: Class Action Filed Alleging Investor Harm

Bronstein, Gewirtz & Grossman LLC Urges Eos Energy Enterprises, Inc. Investors to Act: Class Action Filed Alleging Investor Harm

Bronstein, Gewirtz & Grossman LLC Urges Trip.com Group Limited Investors to Act: Class Action Filed Alleging Investor Harm

Bronstein, Gewirtz & Grossman LLC Urges Alight, Inc. Investors to Act: Class Action Filed Alleging Investor Harm

Bronstein, Gewirtz & Grossman LLC Urges Boston Scientific Corporation Investors to Act: Class Action Filed Alleging Investor Harm

Bronstein, Gewirtz & Grossman LLC Urges ODDITY Tech Ltd. Investors to Act: Class Action Filed Alleging Investor Harm

Bronstein, Gewirtz & Grossman LLC Urges Aldeyra Therapeutics, Inc. Investors to Act: Class Action Filed Alleging Investor Harm

Bronstein, Gewirtz & Grossman LLC Urges Coty Inc. Investors to Act: Class Action Filed Alleging Investor Harm

Bronstein, Gewirtz & Grossman LLC Urges ChowChow Cloud International Holdings Ltd. Investors to Act: Class Action Filed Alleging Investor Harm

Bronstein, Gewirtz & Grossman LLC Urges ImmunityBio, Inc. Investors to Act: Class Action Filed Alleging Investor Harm

Bronstein, Gewirtz & Grossman LLC Urges POET Technologies Inc. Investors to Act: Class Action Filed Alleging Investor Harm

Bronstein, Gewirtz & Grossman LLC Urges Fitness Champs Holdings Ltd. Investors to Act: Class Action Filed Alleging Investor Harm

Bronstein, Gewirtz & Grossman LLC Urges SES AI Corporation Investors to Act: Class Action Filed Alleging Investor Harm

Bronstein, Gewirtz & Grossman LLC Urges Regencell Bioscience Holdings Ltd. Investors to Act: Class Action Filed Alleging Investor Harm

Bronstein, Gewirtz & Grossman LLC Urges Gemini Space Station, Inc. Investors to Act: Class Action Filed Alleging Investor Harm

Bronstein, Gewirtz & Grossman LLC Urges Vital Farms, Inc. Investors to Act: Class Action Filed Alleging Investor Harm

3 Stocks to Sell Before May 19

SLRC faces rate headwinds yet keeps dividend flat; here's what's propping up the stock

IBRX Investor Alert: Kessler Topaz Meltzer & Check, LLP Encourages IBRX Investors with Losses to Contact the Firm

iShares IXUS ETF Outperforms the SPDR NZAC ETF in Yield and 1 Year Return

DRVN DEADLINE: ROSEN, TRUSTED INVESTOR COUNSEL, Encourages Driven Brands Holdings Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - DRVN

Data Center Expert Warns Gigawatt-Scale AI Buildouts Could Trigger Rolling Blackouts

ROSEN, A LEADING LAW FIRM, Encourages POET Technologies Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action First Filed by the Firm - POET

3 Quantum Computing Stocks That Have Massive Upside in May

Jim Cramer on Applied Digital: A $7.5 Billion Contract Isn't Enough Without Profits

A $300,000 Annuity Guarantees $1,900 a Month for Life, but Here Is What Retirees Are Giving Up

The Biggest Reason Microsoft's Earnings Report Was a Disappointment

Berkshire's Greg Abel Marks His First Annual Meeting as CEO. We'd Give Him a B-Plus.

Roblox Stock Slides to New Low as Safety Changes Weigh on Outlook

Prediction: Amazon Stock Is Still a Buy After Hitting All-Time Highs as AWS Revenue Accelerates

Why Peloton Stock Shot Up 27% in April

Which Drone Stock Will Dominate the Next War: AVAV, KTOS, or ONDS?

The “Two Popes” Fed: Why the Warsh-Powell Drama Could Burn Your Retirement Nest Egg

Why Shares of Altria Group Soared in April

Americans Are Waiting Longer to Claim Social Security. Here's Why You May Not Want to Jump on the Bandwagon.

Bank of America: How I Double The Average Dividend Yield

What Is One of the Best Stocks to Buy and Hold for 10 Years?

8 billionaires who fled California before the “Wealth Tax” hit — and one who didn't

Lemonade Stock Sank After Its Q1 2026 Earnings -- Here's the Next Move for Investors

‘I thought the numbers would be much worse’: Trump’s surprising admission as gas prices spike 50%

2 Stocks to Watch as the Quantum Space Gets More Crowded

Dynex Capital May Continue To Disappoint

AGNC Is Yielding 13%, And Top Rated: We Predict A Dividend Hike In 2027

Is B&G Foods Stock a Long-Term Buy?

Elon's Terafab Is Moving at “Light Speed” — and That Could Mean Big Things for Tesla

NYC lost more residents across all income levels in 2025 as Americans flee high-cost blue cities

Universal Logistic Holdings Is Surviving By Underinvesting, But Needs A Quick Turn

AMD: Cooling My Rating, Not My Conviction

At 59, Tapping a $1.5 Million 401(k) First Could Trigger $55,000 in Penalties and Taxes

Suze Orman to 50-Year-Old With $33K Divorce Debt Eyeing 401(k) Withdrawal: ‘Don’t Do It.’

Blue Owl: No Distress Detected

S&P 500 profits haven't been this rich in at least 15 years — but there's more to the story

This Is the Hottest Stock in the Energy Sector. Should You Invest?

The $100 Trillion Buried Under Federal Land That Nobody’s Talking About

AI Meets Crypto: As Automated Trading Gains Momentum, AiTradeBtc Introduces a Fully Managed Quantitative Trading Ecosystem

Donald Trump's Truth Social Stake Hit $4 Billion. Everyday Investors Who Chased the ‘DJT' Meme Stock Have Watched Billions Evaporate

Anchor Loads Up Invesco BulletShares 2029 Corporate Bond ETF With 1.1 Million Shares Bought

Twilio: A Well-Deserved Rerating, Here's When I'll Buy Next

TURPAZ INDUSTRIES ACQUIRES U.S. FLAVOR AND FRAGRANCE COMPANY PHOENIX FOR $95 MILLION

Finally, Some Good News for Tesla Investors

Is iShares' CORO a Buy After TSA Wealth Joined Other Institutional Investors in Purchasing the ETF?

Healthcare Costs Are Rising Faster Than Your Social Security Check. Here's What Retirees Can Do.

Nuveen Core Equity Alpha Fund: Collect An 8% Yield From The Expansion Of The AI Market

Merck: 'Strong Buy' - Terns Acquisition And Ability To Counter Keytruda Patent Loss

Which Is the Better Small-Cap Value ETF, Vanguard's VBR or State Street's SLYV?

3 Biotech Stocks to Watch for Respectable Growth Beyond AI